Literature DB >> 17557345

RLS epidemiology--frequencies, risk factors and methods in population studies.

Klaus Berger1, Tobias Kurth.   

Abstract

Since the introduction of the four minimal criteria for restless legs syndrome (RLS) in 1995 by the International Restless Legs Syndrome Study Group, the number of published studies in RLS during the past 10 years has substantially increased. These studies improved our knowledge about prevalences, risk factors or outcomes of the disease at the population level and provided hypothesis about potential biological mechanism. This article reviews the existing studies on the prevalence and risk factors of RLS and critically describes existing methodological problems in the assessment of the disease in epidemiologic studies.

Entities:  

Mesh:

Year:  2007        PMID: 17557345     DOI: 10.1002/mds.21589

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  22 in total

Review 1.  Restless legs syndrome: a comprehensive overview on its epidemiology, risk factors, and treatment.

Authors:  Paul Yeh; Arthur S Walters; John W Tsuang
Journal:  Sleep Breath       Date:  2011-10-26       Impact factor: 2.816

2.  Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.

Authors:  Heike Benes; Wolfgang Mattern; Ines Peglau; Tillmann Dreykluft; Lars Bergmann; Corinna Hansen; Ralf Kohnen; Norbert Banik; S W Schoen; Magdolna Hornyak
Journal:  J Neurol       Date:  2010-12-28       Impact factor: 4.849

3.  Efficacy of vitamin D replacement therapy in restless legs syndrome: a randomized control trial.

Authors:  Siraj Omar Wali; Bahaa Abaalkhail; Faris Alhejaili; S R Pandi-Perumal
Journal:  Sleep Breath       Date:  2018-11-14       Impact factor: 2.816

4.  Vascular risk factors, cardiovascular disease, and restless legs syndrome in women.

Authors:  Anke C Winter; Markus Schürks; Robert J Glynn; Julie E Buring; J Michael Gaziano; Klaus Berger; Tobias Kurth
Journal:  Am J Med       Date:  2013-03       Impact factor: 4.965

5.  [Practical guidelines for diagnosis and therapy of restless legs syndrome].

Authors:  M Krenzer; W Oertel; C Trenkwalder
Journal:  Nervenarzt       Date:  2014-01       Impact factor: 1.214

Review 6.  Restless legs syndrome: differential diagnosis and management with pramipexole.

Authors:  Francesca Brindani; Francesca Vitetta; Franco Gemignani
Journal:  Clin Interv Aging       Date:  2009-06-29       Impact factor: 4.458

Review 7.  [Perioperative approach to restless legs syndrome].

Authors:  F Bartelke; R Pfister; W Kämmerer
Journal:  Anaesthesist       Date:  2013-12       Impact factor: 1.041

8.  Intravenous iron administration in restless legs syndrome : An observational study in geriatric patients.

Authors:  Benjamin Lieske; Ingrid Becker; Ralf Joachim Schulz; Maria Cristina Polidori; Jan Kassubek; Gabriele Roehrig
Journal:  Z Gerontol Geriatr       Date:  2015-11-23       Impact factor: 1.281

Review 9.  Effect of nonergot dopamine agonists on symptoms of restless legs syndrome.

Authors:  William L Baker; C Michael White; Craig I Coleman
Journal:  Ann Fam Med       Date:  2008 May-Jun       Impact factor: 5.166

Review 10.  Restless legs syndrome associated with major diseases: A systematic review and new concept.

Authors:  Claudia Trenkwalder; Richard Allen; Birgit Högl; Walter Paulus; Juliane Winkelmann
Journal:  Neurology       Date:  2016-03-04       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.